脾切除术对肝硬化的影响及手术相关问题的探讨

孔德刚; 卢实春

doi:10.3969/j.issn.1001-5256.2016.12.033

脾切除术对肝硬化的影响及手术相关问题的探讨

DOI: 10.3969/j.issn.1001-5256.2016.12.033

1. 天津医科大学第二医院肝胆胰外科
2. 中国人民解放军总医院肝胆外科

基金项目:

国家科技支撑计划(2012BAI06B01)；首都卫生发展科研专项(首发2011-2018-03及首发2014-2182)；北京市卫生系统高层次卫生技术人才培养计划(2011-2-18)；

详细信息

中图分类号: R657.6
计量
- 文章访问数: 2118
- HTML全文浏览量: 23
- PDF下载量: 456
- 被引次数: 0
出版历程
- 出版日期: 2016-12-20

Effect of splenectomy on liver cirrhosis and related surgical issues

Research funding:

摘要

摘要: 肝病患者在肝纤维化和肝硬化阶段,脾脏形态功能产生相应变化。是否对肝硬化患者进行脾切除一直以来存有争议。脾切除术作为外科治疗复发性门静脉高压伴食管胃底静脉曲张破裂出血的方法,除能降低门静脉压、减少消化道出血机会及纠正WBC和PLT减少外,还具有改善肝功能、促进肝细胞再生、抑制肝纤维化进展等保护肝脏的作用。结合现有临床及实验室数据,综述了脾切除术对硬化肝脏的影响,以及手术术式选择、术后并发症防治等相关问题,以期对肝硬化患者推广行脾切除术。
- 脾切除术 /
- 肝硬化 /
- 高血压,门静脉 /
- 外科手术 /
- 综述
Abstract: Patients with liver fibrosis and cirrhosis experience certain changes in spleen morphology and function,and there is always a controversy over whether to perform splenectomy in patients with liver cirrhosis. As a surgical treatment of recurrent portal hypertension complicated by esophagogastric variceal bleeding,splenectomy can reduce portal venous pressure,reduce the possibility of gastrointestinal bleeding,and correct the reduced white blood cell count and platelet count. It can also protect the liver by improving liver function,promoting regeneration of hepatocytes,and inhibiting the progression of liver fibrosis. With reference to available clinical and laboratory data,this article reviews the effect of splenectomy on the cirrhotic liver and related issues such as selection of surgical procedures and prevention and treatment of postoperative complications,in order to promote splenectomy in patients with liver cirrhosis.
- splenectomy /
- liver cirrhosis /
- hypertension,portal /
- surgical procedures,operative /
- review

HTML全文

参考文献(33)

[1]AKAHOSHI T,HASHIZUME M,TANOUE K,et al.Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1[J].J Gastroenterol Hepatol,2002,17(1):59-65.

[2]ASANOMA M,IKEMOTO T,MORI H,et al.Cytokine expression in spleen affects progression of liver cirrhosis through liver-spleen cross-talk[J].Hepatol Res,2014,44(12):1217-1223.

[3]CHO JJ,HOCHER B,HERBST H,et al.An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis[J].Gastroenterology,2000,118(6):1169-1178.

[4]CHEN LM,WANG LJ,ZHANG HF,et al.Detection of plateletderived growth factor-AB in patients’sera with hepatic cirrhosis pre-and post-splenectomy[J].Chin J Hepatol,2003,11(12):748.(in Chinese)陈黎明,王陆军,张鸿飞,等.肝硬化患者脾切除术前后血清血小板衍生生长因子-AB检测分析[J].中华肝脏病杂志,2003,11(12):748.

[5] KONG DG.Mechanism of liver-protecting effect of splenectomy in patients with liver cirrhosis[D].Beijing:Capital Med Univ,2015.(in Chinese)孔德刚.脾切除术对肝硬化患者肝脏的保护作用机制研究[D].北京:首都医科大学,2015.

[6]BOYER TD,HABIB S.Big spleens and hypersplenism:fix it or forget it?[J].Liver Int,2015,35(5):1492-1498.

[7] Experts Group from the Ministry of Health Special Fund for Research in the Public Interest.Expert consensus on technical specifications of pericardial devascularization(2013 edition)[J].Chin J Dig Surg,2014,13(1):19-21.(in Chinese)卫生和计划生育委员会卫生公益性行业科研专项专家组.贲门周围血管离断术技术规范专家共识(2013版)[J].中华消化外科杂志,2014,13(1):19-21.

[8]MURATA K,ITO K,YONEDA K,et al.Splenectomy improves liver function in patients with liver cirrhosis[J].Hepatogastroenterology,2008,55(85):1407-1411.

[9]IMURA S,SHIMADA M,UTSUNOMIYA T,et al.Impact of splenectomy in patients with liver cirrhosis:results from 18 patients in a single center experience[J].Hepatol Res,2010,40(9):894-900.

[10]MAKDISSI FF,HERMAN P,PUGLIESE V,et al.Long-term results of esophagogastric devascularization and splenectomy associated with endoscopic treatment in schistosomal portal hypertension[J].World J Surg,2010,34(11):2682-2688.

[11]USHITORA Y,TASHIRO H,TAKAHASHI S,et al.Splenectomy in chronic hepatic disorders:portal vein thrombosis and improvement of liver function[J].Dig Surg,2011,28(1):9-14.

[12]YAMAMOTO N,OKANO K,OSHIMA M,et al.Laparoscopic splenectomy for patients with liver cirrhosis:improvement of liver function in patients with Child-Pugh class B[J].Surgery,2015,158(6):1538-1544.

[13]ZHANG Y,WEN TF,CHEN ZY,et al.Liver functions after periesophagogastric devascularization[J].Chin J Gen Surg,2009,24(6):470-472.(in Chinese)张宇,文天夫,陈哲宇,等.脾切除贲门周围血管离断术后肝脏血流动力学和储备功能的变化[J].中华普通外科杂志,2009,24(6):470-472.

[14]DONG R,DU XL,WANG Q,et al.Laparoscopic versus open splenectomy plus pericardial devascularization for portal hypertension[J].Chin J Gen Surg,2014,29(2):105-107.(in Chinese)董瑞,杜锡林,王青,等.腹腔镜脾切除联合断流术治疗门静脉高压症[J].中华普通外科杂志,2014,29(2):105-107.

[15]EIPEL C,ABSHAGEN K,VOLLMAR B.Regulation of hepatic blood flow:the hepatic arterial buffer response revisited[J].World J Gastroenterol,2010,16(48):6046-6057.

[16]HU LS,GEORGE J,WANG JH.Current concepts on the role of nitric oxide in portal hypertension[J].World J Gastroenterol,2013,19(11):1707-1717.

[17]MURATA K,SHIRAKI K,SUGIMOTO K,et al.Splenectomy enhances liver regeneration through tumor necrosis factor(TNF)-alpha following dimethylnitrosamine-induced cirrhotic rat model[J].Hepatogastroenterology,2001,48(40):1022-1027.

[18]MEIJER C,WIEZER MJ,DIEHL AM,et al.Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy[J].Liver,2000,20(1):66-77.

[19]MORINAGA A,OGATA T,KAGE M,et al.Comparison of liver regeneration after a splenectomy and splenic artery ligation in a dimethylnitrosamine-induced cirrhotic rat model[J].HPB(Oxford),2010,12(1):22-30.

[20]YAMADA S,MORINE Y,IMURA S,et al.Liver regeneration after splenectomy in patients with liver cirrhosis[J].Hepatol Res,2016,46(5):443-449.

[21]WANG JF,CHEN J,LIU XS.The effects of devascularization procedure on serum HGF,TGF-β1 and cirrhotic serum markers of portal hypertensive patients[J].J Hepatopancreatobiliary Surg,2013,25(1):31-34.(in Chinese)汪家富,陈坚,刘绪舜.断流术对门静脉高压症患者血清HGF、TGF-β1及肝纤维化血清学指标的影响[J].肝胆胰外科杂志,2013,25(1):31-34.

[22]ELSEBAE MM,ABU-ZEKRI NB.A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers.A prospective study[J].Int J Surg,2008,6(5):362-366.

[23]KONG D,CHEN X,LU S,et al.Short-term effects of splenectomy on serum fibrosis indexes in liver cirrhosis patients[J].Int J Clin Exp Pathol,2015,8(11):15260-15264.

[24]IWAMOTO T,TERAI S,MIZUNAGA Y,et al.Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients[J].J Gastroenterol,2012,47(3):300-312.

[25]YADA A,IIMURO Y,UYAMA N,et al.Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6Clo macrophages[J].J Hepatol,2015,63(4):905-916.

[26]QI X,HAN G,YE C,et al.Splenectomy causes 10-fold increased risk of portal venous system thrombosis in liver cirrhosis patients[J].Med Sci Monit,2016,22:2528-2550.

[27]YANG Z.Selective pericardial devascularization[J].J Clin Surg,2004,12(7):393-394.(in Chinese)杨镇.选择性贲门周围血管离断术[J].临床外科杂志,2004,12(7):393-394.

[28]YU H,GUO S,WANG L,et al.Laparoscopic splenectomy and esophagogastric devascularization for liver cirrhosis and portal hypertension is a safe,effective,and minimally invasive operation[J].J Laparoendosc Adv Surg Tech A,2016,26(7):524-530.

[29]HUANG JW.Research advances in laparoscopic splenectomy[J].Chin J Min Inv Surg,2014,14(2):176-179.(in Chinese)黄军伟.腹腔镜脾切除术研究的进展[J].中国微创外科杂志,2014,14(2):176-179.

[30]ZHOU JH,WU LM,WANG JH,et al.Postopetive complications of laparoscopic splenectomy in patients with portal hypertension[J].J Clin Hepatol,2025,31(11):1870-1873.(in Chinese)周晋航,吴黎明,王江华,等.肝硬化门静脉高压症患者腹腔镜脾切除术后并发症相关因素分析[J].临床肝胆病杂志,2015,31(11):1870-1873.

[31]YERDEL MA,GUNSON B,MIRZA D,et al.Portal vein thrombosis in adults undergoing liver transplantation:risk factors,screening,management,and outcome[J].Transplantation,2000,69(9):1873-1881.

[32]LAI W,LU SC,LI GY,et al.Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization[J].World J Gastroenterol,2012,18(26):3443-3450.

[33]ZENG DB,DAI CZ,LU SC,et al.Abnormal splenic artery diameter/hepatic artery diameter ratio in cirrhosis-induced portal hypertension[J].World J Gastroenterol,2013,19(8):1292-1298.

施引文献

资源附件(0)

访问统计